aztreonam has been researched along with Lymphoma, Non-Hodgkin in 1 studies
Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.
Lymphoma, Non-Hodgkin: Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Aztreonam was discontinued in both patients." | 1.28 | Toxic epidermal necrolysis possibly linked to aztreonam in bone marrow transplant patients. ( Bianco, JA; McDonald, BJ; Singer, JW, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McDonald, BJ | 1 |
| Singer, JW | 1 |
| Bianco, JA | 1 |
1 other study available for aztreonam and Lymphoma, Non-Hodgkin
| Article | Year |
|---|---|
Toxic epidermal necrolysis possibly linked to aztreonam in bone marrow transplant patients.
Topics: Adult; Aztreonam; Bacterial Infections; Bone Marrow Transplantation; Graft vs Host Disease; Humans; | 1992 |